Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal...

Por Johnson, Melissa L., Riely, Greg J., Rizvi, Naiyer A., Azzoli, Christopher G., Kris, Mark G., Sima, Camelia S., Ginsberg, Michelle S., Pao, William, Miller, Vincent A.
Publicado em 2011

A double-blind randomized discontinuation phase II study of sorafenib (BAY 43-9006) in previously...

Por Wakelee, Heather A., Lee, Ju-Whei, Hanna, Nasser H., Traynor, Anne M., Carbone, David P., Schiller, Joan H.
Publicado em 2012

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

Por Cortes, Javier, Hudgens, Stacie, Twelves, Chris, Perez, Edith A., Awada, Ahmad, Yelle, Louise, McCutcheon, Susan, Kaufman, Peter A., Forsythe, Anna, Velikova, Galina
Publicado no Breast Cancer Res Treat (2015)

Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.

Por Weir, D C, Gove, R I, Robertson, A S, Burge, P S
Publicado em 1990

Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung...

Por Zahra, Amir, Fath, Melissa A., Opat, Emyleigh, Mapuskar, Kranti A., Bhatia, Sudershan K., Ma, Daniel C., Rodman, Samuel N., Snyders, Travis P., Chenard, Catherine A., Eichenberger-Gilmore, Julie M., Bodeker, Kellie L., Ahmann, Logan, Smith, Brian J., Vollstedt, Sandy A., Brown, Heather A., Hejleh, Taher Abu, Clamon, Gerald H., Berg, Daniel J., Szweda, Luke I., Spitz, Douglas R., Buatti, John M., Allen, Bryan G.
Publicado no Radiat Res (2017)

Antiviral activity of dolutegravir in subjects with failure on an integrase inhibitor-based regimen: week 24 phase 3 results from VIKING-3

Por Nichols, G, Mills, A, Grossberg, R, Lazzarin, A, Maggiolo, F, Molina, J, Pialoux, G, Wright, D, Ait-Khaled, M, Huang, J, Vavro, C, Wynne, B, Yeo, J
Publicado em 2012

SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0341) OF ERLOTINIB (OSI-774) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND A PERFORMANCE STATUS OF 2

Por Hesketh, Paul J., Chansky, Kari, Wozniak, Antoinette J., Hirsch, Fred R., Spreafico, Anna, Moon, James, Mack, Philip C., Marchello, Benjamin T., Franklin, Wilbur A., Crowley, John J., Gandara, David R.
Publicado em 2008

Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic Malignancies

Por Kunos, Charles A., Brindle, James, Waggoner, Steven, Zanotti, Kristine, Resnick, Kimberly, Fusco, Nancy, Adams, Ramon, Debernardo, Robert
Publicado em 2012

Vandetanib and indwelling pleural catheter for non-small cell lung cancer with recurrent malignant pleural effusion

Por Massarelli, Erminia, Onn, Amir, Marom, Edith M., Alden, Christine M., Liu, Diane D., Tran, Hai T., Mino, Barbara, Wistuba, Ignacio I., Faiz, Saadia A., Bashoura, Lara, Eapen, George A., Morice, Rodolfo C., Jack Lee, J., Hong, Waun K., Herbst, Roy S., Jimenez, Carlos A.
Publicado em 2014

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study

Por Hong, C‐H., Papp, K.A., Lophaven, K.W., Skallerup, P., Philipp, S.
Publicado no J Eur Acad Dermatol Venereol (2017)

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.

Por Pyrhönen, S., Valavaara, R., Modig, H., Pawlicki, M., Pienkowski, T., Gundersen, S., Bauer, J., Westman, G., Lundgren, S., Blanco, G., Mella, O., Nilsson, I., Hietanen, T., Hindy, I., Vuorinen, J., Hajba, A.
Publicado em 1997

A Phase III Randomized, Double Blind, Placebo-Controlled Study of Pilocarpine for Vaginal Dryness: NCCTG study N04CA

Por Loprinzi, Charles L., Balcueva, Ernie P., Liu, Heshan, Sloan, Jeff A., Kottschade, Lisa A., Stella, Philip J., Carlson, Mark D., Moore, Dennis F., Zon, Robin T., Levitt, Ralph, Jaslowski, Anthony J.
Publicado em 2011

Thymidylate Synthase (TYMS) Enhancer Region Genotype-Directed Phase II Trial of Oral Capecitabine for 2nd Line Treatment of Advanced Pancreatic Cancer

Por Weekes, Colin D., Nallapareddy, Sujatha, Rudek, Michelle A., Norris-Kirby, Alexis, Laheru, Daniel, Jimeno, Antonio, Donehower, Ross C., Murphy, Kathleen M., Hidalgo, Manuel, Baker, Sharyn D., Messersmith, Wells A.
Publicado em 2010

Use of the Hedgehog signaling pathway inhibitor in the treatment of recurrent locally advanced and metastatic basal cell skin cancer

Por Z. A.-G. Radzhabova, M. A. Kotov, Z. S. Bekyasheva, M. A. Radzhabova, E. V. Levchenko
Publicado em 2020-02-01

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

Por Robison, Nathan J, Campigotto, Federico, Chi, Susan N, Manley, Peter E, Turner, Christopher D, Zimmerman, Mary Ann, Chordas, Christine A, Werger, Annette M, Allen, Jeffrey C, Goldman, Stewart, Rubin, Joshua B, Isakoff, Michael S, Pan, Wilbur J, Khatib, Ziad A, Comito, Melanie A, Bendel, Anne E, Pietrantonio, Jay B, Kondrat, Laura, Hubbs, Shannon M, Neuberg, Donna S, Kieran, Mark W
Publicado no Pediatr Blood Cancer (2014)

A phase II trial of abiraterone combined with dutasteride for men with metastatic castration-resistant prostate cancer

Por McKay, Rana R., Werner, Lillian, Mostaghel, Elahe A., Lis, Rosina, Voznesensky, Olga, Zhang, Zhenwei, Marck, Brett T., Matsumoto, Alvin M., Domachevsky, Liran, Zukotynski, Katherine A., Bhasin, Manoj, Bubley, Glenn J., Montgomery, Bruce, Kantoff, Philip W., Balk, Steven P., Taplin, Mary-Ellen
Publicado no Clin Cancer Res (2016)

Alteration of Daily and Circadian Rhythms following Dopamine Depletion in MPTP Treated Non-Human Primates

Por Fifel, Karim, Vezoli, Julien, Dzahini, Kwamivi, Claustrat, Bruno, Leviel, Vincent, Kennedy, Henry, Procyk, Emmanuel, Dkhissi-Benyahya, Ouria, Gronfier, Claude, Cooper, Howard M.
Publicado em 2014

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non...

Por Dy, Grace K., Hillman, Shauna L., Rowland, Kendrith M., Molina, Julian R., Steen, Preston D., Wender, Donald B., Nair, Suresh, Mandrekar, Sumithra, Schild, Steven E., Adjei, Alex A.
Publicado no Cancer (2010)

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

Por Kwak, Eunice L., Bang, Yung-Jue, Camidge, D. Ross, Shaw, Alice T., Solomon, Benjamin, Maki, Robert G., Ou, Sai-Hong I., Dezube, Bruce J., Jänne, Pasi A., Costa, Daniel B., Varella-Garcia, Marileila, Kim, Woo-Ho, Lynch, Thomas J., Fidias, Panos, Stubbs, Hannah, Engelman, Jeffrey A., Sequist, Lecia V., Tan, WeiWei, Gandhi, Leena, Mino-Kenudson, Mari, Wei, Greg C., Shreeve, S. Martin, Ratain, Mark J., Settleman, Jeffrey, Christensen, James G., Haber, Daniel A., Wilner, Keith, Salgia, Ravi, Shapiro, Geoffrey I., Clark, Jeffrey W., Iafrate, A. John
Publicado em 2010

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent...

Por Zhao, Yujie, Foster, Nathan R., Meyers, Jeffrey P., Thomas, Sachdev P., Northfelt, Donald W., Rowland, Kendrith M., Mattar, Bassam I., Johnson, David B., Molina, Julian R., Mandrekar, Sumithra J., Schild, Steven E., Bearden, James D., Aubry, Marie-Christine, Adjei, Alex A.
Publicado no J Thorac Oncol (2015)